Key Players
- The Liposomal Doxorubicin market is consolidated at the top
- dominated by the originator Johnson & AND companies IS NULL; Johnson (Janssen)
- Johnson & AND companies IS NULL; Johnson Services Inc.
- Merck & AND companies IS NULL; Co. Inc.
- Cadila Pharmaceuticals Ltd.
- Cipla Limited
- GlaxoSmithKline plc
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Baxter International Inc.
